Columbus McKinnon Corporation — Form 10-Q Summary
Business context and reporting period
Columbus McKinnon designs, manufactures and markets motion-control and material-handling products, including hoists, actuators, rigging tools, workstations, and digital power and motion-control systems. The filing covers the three and nine months ended December 31, 2019, representing the third quarter and first nine months of fiscal 2020. Approximately 45% of nine-month revenue came from outside the United States.
Key financial metrics
| Metric | Three months ended Dec. 31, 2019 | Three months ended Dec. 31, 2018 | Nine months ended Dec. 31, 2019 | Nine months ended Dec. 31, 2018 |
|---|---|---|---|---|
| Net sales | $199.4 million | $217.4 million | $619.7 million | $659.5 million |
| Gross profit | $67.9 million | $73.4 million | $217.0 million | $229.0 million |
| Gross margin | 34.0% | 33.8% | 35.0% | 34.7% |
| Operating income | $20.9 million | $6.6 million | $73.2 million | $45.0 million |
| Net income | $15.3 million | $(0.8) million | $50.4 million | $22.8 million |
| Diluted EPS | $0.63 | $(0.03) | $2.11 | $0.97 |
| Cash flow from operations | Not separately provided | Not separately provided | $70.3 million | $53.8 million |
At December 31, 2019, cash and cash equivalents were $84.0 million, compared with $71.1 million at March 31, 2019. Cash, cash equivalents and restricted cash totaled $84.3 million. Total debt carrying value was approximately $251.9 million, consisting primarily of a $260.5 million term-loan principal balance less deferred financing costs; $65.0 million was classified as current. The company had no Revolver borrowings and $16.1 million of outstanding letters of credit. Total assets were $1.08 billion and shareholders’ equity was $484.4 million.
Nine-month investing cash use was $7.0 million, including $6.8 million of capital expenditures. Financing cash use was $50.4 million, including $50.0 million of debt repayment and $4.2 million of dividends. Management stated that cash, operating cash flow and available borrowing capacity should fund operations, capital expenditures and debt obligations for at least the next twelve months, subject to execution of its business plan and effective working-capital management.
Material changes versus the prior comparable period
- Third-quarter sales decreased 8.3%, primarily from lower volume, unfavorable foreign-currency translation and the absence of revenue from businesses sold in fiscal 2019. Price increases partially offset these effects.
- Nine-month sales declined 6.0%. Businesses sold in fiscal 2019 reduced comparable revenue by $29.3 million, lower volume reduced revenue by $10.0 million, and foreign-currency translation reduced revenue by $10.8 million; price increases contributed $10.3 million.
- Gross margins improved despite lower gross profit, rising to 34.0% in the quarter and 35.0% year to date from 33.8% and 34.7%, respectively.
- Operating income and net income improved substantially because the prior-year periods included significant losses and impairment charges related to businesses held for sale. The current nine-month period included only a $0.2 million final working-capital adjustment related to those divestitures versus a $26.7 million prior-year loss.
- General and administrative expense benefited from lower incentive and stock compensation, including a $2.0 million reversal related to the departing CEO’s forfeited awards. These savings were partly offset by facility-consolidation and Asia-Pacific reorganization costs.
- Operating cash flow increased $16.5 million year over year, aided by lower inventory and receivables and higher earnings.
- The company repaid $50.0 million of term debt during the nine months, reducing leverage and interest expense. Interest and debt expense declined to $11.0 million from $13.2 million.
Guidance, outlook, commentary and risks
- Management expects a fiscal 2020 effective tax rate of approximately 21% to 22%. The current period benefited from a $1.9 million tax benefit related to utilization of previously reserved foreign tax credits.
- Fiscal 2020 capital expenditures are expected to be approximately $10 million to $12 million, excluding acquisitions and strategic alliances.
- Management is consolidating manufacturing facilities, including the Lisbon, Ohio facility with operations in Wadesboro, North Carolina and Damascus, Virginia, and consolidating one of two Hangzhou, China facilities. Related costs were recorded in the current period.
- Management estimates approximately $2.5 million of fiscal 2020 tariff exposure related to China, with mitigation efforts focused on productivity and pricing.
- The company is pursuing its Blueprint for Growth strategy, emphasizing business simplification, operational excellence, new product development, digital capabilities, margin expansion and improved return on invested capital.
- Key risks include cyclical industrial demand, steel and tariff costs, foreign-currency movements, facility consolidations, acquisition integration, goodwill impairment, asbestos and product-liability claims, and the transition away from LIBOR. The company reported no material changes to other previously disclosed market risks.
- Asbestos-related liability was estimated at $4.9 million, within an actuarial range of $3.6 million to $6.5 million; approximately $2.0 million of payments were expected over the next twelve months. Product-related liability reserves were approximately $6.0 million.
- The filing reports no pending legal proceeding expected to have a material impact, no defaults, and effective disclosure controls as of December 31, 2019.
Most important facts for investors to verify
- Whether lower volume and global industrial weakness persist and pressure revenue despite pricing actions.
- Progress and one-time costs associated with the Ohio and China facility consolidations.
- Execution of planned $65.0 million total debt paydown over the following twelve months and compliance with debt terms as LIBOR is phased out.
- Actual tariff exposure and the extent to which pricing and productivity actions offset it.
- Sustainability of the improved gross margin and the extent to which prior-year divestiture charges and CEO compensation reversals distort year-over-year comparisons.
- Future asbestos, product-liability, environmental and Monsanto-related indemnification exposure, including potential earnings volatility from unrecorded or uncertain claims.
- Potential goodwill impairment if forecast revenue, margins or discount-rate assumptions deteriorate.